Ascendance Biotechnology's Corporate Minority Round

Ascendance Biotechnology raised a round of funding on November 07, 2015.

Ascendance Biotechnology is was formed by BioTime and Hepregen Corporation to address the In Vitro cell biology market. Ascendance combines Hepregen's application-directed, cellular micro-patterning d…

Articles about Ascendance Biotechnology's Corporate Minority Round: